Market Overview

Sorrento Therapeutics Could IPO Its Scilex Unit


Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced it's exploring the possibility of an initial public offering of its majority-owned subsidiary, Scilex Holding.

Scilex Holding is a pharmaceutical company that delivers pain management products.

No decisions have been made at this point on the structure or timing of the possible IPO, and no assurance can be given that an IPO will be pursued or completed.

Invest in IPO shares before the stock hits the market with ClickIPO. Check it out here

Sorrento's stock closed Tuesday at $2.99 per share.

Posted-In: Scilex HoldingNews IPOs


Related Articles (SRNE)

View Comments and Join the Discussion!

Scoop: Cannabis Decontamination Tech Company Willow Industries Closes $2M Funding Round

The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana